Results 11 to 20 of about 170,341 (384)

Ovarian Neoplasms: Clinicopathological Spectrum in Tribal Rajasthan, India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: Ovarian neoplasms have increased in incidence in leading sites of cancer in five old population based cancer registries on comparing first ten and last ten years data.
Geeta Mukhiya   +2 more
doaj   +1 more source

Intraoperative Cytology of Ovarian Neoplasms with an Attempt to Grade Epithelial Tumors.

open access: diamondJ Cytol, 2018
Bohara S   +5 more
europepmc   +2 more sources

Feline Ovarian Neoplasms [PDF]

open access: yesVeterinary Pathology, 1985
Primary ovarian neoplasms from 22 cats were described. A single cat had tumors of epithelial origin—bilateral cystadenomas. Seven animals had germ cell tumors—dysgerminomas or teratomas; two cats had bilateral tumors. Fourteen animals had neoplasms of sex cord-stromal origin—granulosa cell tumors and interstitial gland tumors. Four cats with granulosa
Howard B. Gelberg, K. McEntee
openaire   +3 more sources

Issues and Challenges in Diagnoses of Borderline Ovarian Neoplasms by Frozen Section

open access: yesAsian Pacific Journal of Cancer Biology, 2023
Introduction: Frozen section is a rapid intraoperative method of tissue sectioning with the help of cryostat to arrive at a diagnosis and guide the operative procedure.
Usha Sarma   +2 more
doaj   +1 more source

Differences in Stromal Immunostaining of Tumour Necrosis Factor-alpha and its Receptors in Neoplastic and Non Neoplastic Ovarian Lesions: A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Ovarian cancer has an unknown pathogenesis, and cytokines may play an important role in the aetiology and prognosis. Tumour Necrosis Factor-alpha (TNF-α) and its receptors (TNFR1 and TNFR2) are involved in the biology of ovarian cancer ...
Rosekeila Simões Nomelini   +5 more
doaj   +1 more source

Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience. [PDF]

open access: yes, 2016
BackgroundHER2/neu overexpression and/or amplification has been widely studied in a number of solid tumors, primarily in the breast. In gynecologic neoplasms, determination of HER2/neu status has not been well studied as a predictive biomarker in anti ...
Apple, Sophia K   +5 more
core   +2 more sources

Serum anti-Müllerian hormone concentrations before and after treatment of an ovarian granulosa cell tumour in a cat [PDF]

open access: yes, 2017
Case summary A 15-year-old female cat was presented for investigation of progressive behavioural changes, polyuria, polydipsia and periuria. An ovarian granulosa cell tumour was identified and the cat underwent therapeutic ovariohysterectomy (OHE).
Fowkes, R C   +8 more
core   +2 more sources

Co‐existing monophasic teratoma and uterine adenocarcinoma in a female dog [PDF]

open access: yes, 2019
Ovarian teratomas are occasionally reported in dogs; the rarest type is the monophasic teratoma,composed of tissues originating from only one germ layer. Canine endometrial adenocarcinomas are also rare in dogs and mainly affect geriatric females.
Catarino, J.C   +8 more
core   +2 more sources

An incidental finding of benign Brenner tumor in mucinous cystadenoma of ovary: a case report [PDF]

open access: yesJournal of Krishna Institute of Medical Sciences University, 2022
Ovarian tumors are common neoplasia in women. Ovarian carcinoma accounts for the 7 cause of mortality and morbidity in females. Surface epithelial tumors are the most common type of ovarian tumor.
Sneha Samir Babaria   +3 more
doaj  

Bilateral malignant ovarian tumor: a rare combination of mixed epithelial tumor - serous adenocarcinoma with Brenner’s and pure Brenner’s tumor [PDF]

open access: yesNew Indian Journal of OBGYN, 2023
Mixed epithelial ovarian tumors, by definition are composed of admixtures of two or more of the five major cell types: serous, mucinous, endometroid, clear cell and Brenner/ transitional.
Sonia H, Bhavya HU , Geeta J Doppa
doaj   +1 more source

Home - About - Disclaimer - Privacy